Early disease detection
Hummingbird extracts deep insights into disease through the integrated analysis of both tumor and immune system derived small RNA biomarkers from whole blood.
This dual interrogation of signal from disease and the host response to disease enables a highly sensitive, robust, and AI powered platform that will revolutionize how we diagnose, treat, and manage cancer and other diseases.
Next generation of blood tests
UPDATES ON THE LATEST DEVELOPMENTS
Explore our pipeline of proprietary blood tests under development.
Hummingbird Diagnostics Announces Initiation of Patient Recruitment for Clinical Study Evaluating miLungDx as a Novel Diagnostic Test for Early-stage Lung Cancer.
Learn more about genomic biomarkers and read publications from the biomarker field.